With advanced imaging and targeted therapies, doctors can now “see what they treat, and treat what they see”. We explore how nuclear medicine is delivering on this promise for prostate cancer – from improving diagnosis to therapy options – and what are the challenges that patients face in accessing nuclear medicine therapy.
